Skip to main content
U.S. flag

An official website of the United States government

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you’ve safely connected to the .gov website. Share sensitive information only on official, secure websites.

Search help
91 results
  1. NLM Digital Collections - Single-Drug Therapy for Hypertension in Men: A Comparison of Six Antihypertensive Agents with ... 
    Publication: Massachusetts Medical Society, 1 April 1993
    resource.nlm.nih.gov/101584929X130
    ... of 95 to 109 mm Hg, after a placebo washout period, to receive placebo or one of six ... maintenance phase, each patient entered a four-week placebo washout phase. Patients who had been randomly assigned to ...
  2. NLM Digital Collections - Modulator treatments for cystic fibrosis : effectiveness and value 
    Publication: [Boston, Massachusetts] : Institute for Clinical and Economic Review, April 27, 2020
    resource.nlm.nih.gov/101769589
    ... 4.4 (0 to without appropriate 18.3) washout Placebo: 7.3 (5.2 to 8.2) Difference ... between) 98.5 (6.4) difference (p-value) washout for 4 −2.22 (p=0.0097) weeks, and 150mg placebo every 12 hours for 4 weeks OR (2) ...
  3. NLM Digital Collections - Modulator treatments for cystic fibrosis : effectiveness and value : final evidence report ... 
    Publication: [Boston, Massachusetts] : Institute for Clinical and Economic Review, June 7, 2018
    resource.nlm.nih.gov/101744956
    ... four- weeks, and 150mg Mean, percentage value) week washout placebo every 12 hours points (SD) −2.22 (p= ... twice daily, BMI Ivacaftor: 83.33 28-day washout period, Mean, kg (SD) Placebo: 79.97 (1) 22.7 (6.96) ©Institute ...
  4. NLM Digital Collections - Response to a Second Single Antihypertensive Agent Used as Monotherapy for Hypertension after ... 
    Publication: The American Medical Association, 11 September 1995
    resource.nlm.nih.gov/101584929X123
    ... failed an active treatment and withdrew during the placebo washout phase, the com- bined response rate was 76. ...
  5. Results - Medical Therapies for Children With Autism Spectrum Disorder—An Update - NCBI Bookshelf 
    https://www.ncbi.nlm.nih.gov/books/NBK448267
    ... with moderate risk of bias compared melatonin or placebo for 3 months followed by a 1-month washout and 3 months of either melatonin or placebo. 68 Sleep latency and total sleep were significantly ...
  6. NLM Digital Collections - Primary care services : promoting optimal child development from birth to three years 
    Publication: New York, NY : Commonwealth Fund, [2002]
    resource.nlm.nih.gov/101162589
    ... 2 week baseline–4 weeks of drug or placebo–1 week washout–4 weeks of Limitations to generalizability: This sample ...
  7. Findings - Psychosocial and Pharmacologic Interventions for Disruptive Behavior in Children and Adolescents - NCBI ... 
    https://www.ncbi.nlm.nih.gov/books/NBK327212
    ... 69), or 40 mg/day (n = 61) or placebo (n = 60) for 4 weeks with forced dose escalation after a washout period. Eligible participants were aged 6 to 17 ... atomoxetine-slow titrating group, n = 61); or (3) placebo (n = 59) for nine ... screening and washout period. The primary outcome was the investigator-rated ...
  8. Symptomatic pharmacological therapy in Parkinson’s disease - Parkinson's Disease - NCBI Bookshelf 
    https://www.ncbi.nlm.nih.gov/books/NBK48523
    ... three levodopa groups worsened during the 2-week washout period but did not deteriorate to placebo levels. The group receiving the highest dose of ... and 311 (86%) completed the 2 weeks of washout. The percentage of dropouts per group included: placebo (22%), 150 mg/d (15%), 300 mg/d ( ...
  9. NLM Digital Collections - Vesicular monoamine transporter 2 inhibitors for tardive dyskinesia : effectiveness and value ... 
    Publication: [Boston, Massachusetts] : Institute for Clinical and Economic Review, December 22, 2017
    resource.nlm.nih.gov/101723938
    ... 17.8) followed by 4 (combined w/ prior placebo disorder/mood disorder, n (%) weeks washout group) 2) 61 (64.9)/33 (35.1) ... 7 (9.6) 2) 2.4 VE and Washout periods 2) 47.2 (11.2) 3) 2.2 2) VBZ 40 mg/day, n=97 3) 47.6 (13.6) (combined w/ prior placebo group) Male, n (%) 1) 34 (68.0) 3) ...
  10. Management of Cancer Symptoms: Pain, Depression, and Fatigue : Summary - AHRQ Evidence Report Summaries - NCBI Bookshelf 
    https://www.ncbi.nlm.nih.gov/books/NBK11961
    ... true in the past; apply blinding and active placebos when appropriate, or uniform control treatments otherwise; employ adequate between-arm washout intervals and consider advancing disease state in crossover ...
first · previous · 1 · 2 · 3 · 4 · 5 · 6 · 7 · 8 · 9 · next · last